Form 8-K - Current report:
SEC Accession No. 0001437749-23-008705
Filing Date
2023-03-31
Accepted
2023-03-31 08:30:26
Documents
15
Period of Report
2023-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bkyi20230330_8k.htm   iXBRL 8-K 31051
2 EXHIBIT 99.1 ex_495616.htm EX-99.1 180749
7 logo.jpg GRAPHIC 11407
  Complete submission text file 0001437749-23-008705.txt   379918

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bkyi-20230331.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bkyi-20230331_def.xml EX-101.DEF 11920
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bkyi-20230331_lab.xml EX-101.LAB 15967
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bkyi-20230331_pre.xml EX-101.PRE 12131
9 EXTRACTED XBRL INSTANCE DOCUMENT bkyi20230330_8k_htm.xml XML 2661
Mailing Address 3349 HIGHWAY 138 BUIDING A, SUITE E WALL NJ 07719
Business Address 3349 HIGHWAY 138 BUIDING A, SUITE E WALL NJ 07719 7323591100
BIO KEY INTERNATIONAL INC (Filer) CIK: 0001019034 (see all company filings)

EIN.: 411761861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13463 | Film No.: 23783420
SIC: 7372 Services-Prepackaged Software